Technology | November 03, 2010

Automated Gating Protects Against Unintended Radiation

November 3, 2010 – A new system cleared by the U.S. Food and Drug Administration (FDA) automates the response to organ motion that occurs during the delivery of radiation to prostate cancer tumors. Dynamic EdgeT Gating Technology, by Calypso Medical Technologies, is designed to protect healthy tissue from unintended radiation.

The technology will be on display at the American Society for Radiation Oncology (ASTRO) conference in San Diego, Calif.

It allows therapists to set motion thresholds which disable radiation delivery if the targeted tissue moves outside the preset threshold. Previously, the therapist had to manually intervene when healthy tissue was in danger of receiving unintended radiation. Dynamic Edge Gating provides an immediate response so the radiation beam is automatically disabled or re-enabled in response to organ motion. As a result, it may help decrease the side effects associated with prostate radiotherapy, such as bowel and bladder incontinence and sexual dysfunction.

The Calypso System, with its GPS for the Body technology, utilizes miniature implanted Beacon transponders to provide precise, continuous information on the location of the tumor during external beam radiation therapy.

For more information: www.calypsomedical.com

Related Content

Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
The patient’s wife changes the Optune array. Clinical trials indicate that the electrical fields emitted by Optune have the potential to lengthen the lives of patients with glioblastoma.

The patient’s wife changes the Optune array. Clinical trials indicate that the electrical fields emitted by Optune have the potential to lengthen the lives of patients with glioblastoma.

Feature | Radiation Oncology | November 06, 2018 | By Greg Freiherr
Approximately 11,000 professionals attended the four-day meeting of the...